164 related articles for article (PubMed ID: 19487235)
1. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial.
Tolosana JM; Berne P; Mont L; Heras M; Berruezo A; Monteagudo J; Tamborero D; Benito B; Brugada J
Eur Heart J; 2009 Aug; 30(15):1880-4. PubMed ID: 19487235
[TBL] [Abstract][Full Text] [Related]
2. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.
Masiero S; Connolly SJ; Birnie D; Neuzner J; Hohnloser SH; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Wang J; Mabo P; Glikson M; Kutyifa V; Wright DJ; Essebag V; Healey JS;
Europace; 2017 Jun; 19(6):1002-1006. PubMed ID: 27353323
[TBL] [Abstract][Full Text] [Related]
3. Continue or withhold oral anticoagulation in high-risk patients undergoing pacemaker or ICD implantation.
Daubert JC; Mabo P
Eur Heart J; 2009 Aug; 30(15):1828a-1828c. PubMed ID: 19717508
[No Abstract] [Full Text] [Related]
4. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
[TBL] [Abstract][Full Text] [Related]
5. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.
Michaud GF; Pelosi F; Noble MD; Knight BP; Morady F; Strickberger SA
J Am Coll Cardiol; 2000 Jun; 35(7):1915-8. PubMed ID: 10841243
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
[TBL] [Abstract][Full Text] [Related]
8. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
9. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
10. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
Du L; Zhang Y; Wang W; Hou Y
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
[TBL] [Abstract][Full Text] [Related]
11. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
Jamula E; Douketis JD; Schulman S
J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
[TBL] [Abstract][Full Text] [Related]
12. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
Cheng A; Nazarian S; Brinker JA; Tompkins C; Spragg DD; Leng CT; Halperin H; Tandri H; Sinha SK; Marine JE; Calkins H; Tomaselli GF; Berger RD; Henrikson CA
Heart Rhythm; 2011 Apr; 8(4):536-40. PubMed ID: 21147261
[TBL] [Abstract][Full Text] [Related]
13. Pacemaker or defibrillator surgery without interruption of anticoagulation.
Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
[TBL] [Abstract][Full Text] [Related]
14. Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: the StimAOD multicentre prospective study.
Martin AC; Weizman O; Sellal JM; Algalarrondo V; Amara W; Bouzeman A; Gandjbakhch E; Lellouche N; Louembe J; Menet A; Roumegou P; Treguer F; Godier A; Boveda S; Garcia R; Marijon E
Europace; 2023 May; 25(5):. PubMed ID: 36932714
[TBL] [Abstract][Full Text] [Related]
15. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
[TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
17. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
Birnie DH; Healey JS; Wells GA; Ayala-Paredes F; Coutu B; Sumner GL; Becker G; Verma A; Philippon F; Kalfon E; Eikelboom J; Sandhu RK; Nery PB; Lellouche N; Connolly SJ; Sapp J; Essebag V
Eur Heart J; 2018 Nov; 39(44):3973-3979. PubMed ID: 30462279
[TBL] [Abstract][Full Text] [Related]
18. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.
Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A
Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073
[TBL] [Abstract][Full Text] [Related]
19. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
